Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Technologies for Substance Use Disorders
N/A
Recruiting
Led By Hans Morefield
Research Sponsored by Chess Mobile Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month, 6 month
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study the effectiveness of a new version of an online intervention for individuals with moderate to high risk drug or alcohol use or Substance Use Disorder. The study will compare this new intervention with the
Who is the study for?
This trial is for adults over 18 receiving primary care in Western Michigan who have a substance-specific NIDA Modified Assist score of 27 or greater, indicating moderate to high risk drug or alcohol use.
What is being tested?
The study tests the effectiveness of an enhanced CHESS Health eIntervention versus standard treatment (SBIRT/TAU) in reducing substance use and improving treatment enrollment among those at moderate to high risk for Substance Use Disorders.
What are the potential side effects?
Since this trial involves behavioral interventions and not medications, traditional side effects are not applicable. However, participants may experience discomfort discussing personal substance use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-month, 6 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month, 6 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Contemplation ladder
Demographics
Healthcare utilization
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: SBIRT/eIntervention those assessed with high risk.Experimental Treatment1 Intervention
Subjects assigned to this condition will be instructed by the research assistant in how to download and use the eIntervention app, which they will be free to use as they like for the duration of the study. The app will contain a personalized suite of programs and activities. Unlike the TAU condition, the patient's referral to treatment would be managed through eIntervention. For example, the app will show the patient their referral details (if a referral to treatment was made), including details on the provider, referred services, and contact information, and will offer them videos of peers and professionals educating them on addiction, treatment, and sharing personal stories of recovery.
Group II: SBIRT/eIntervention for those with moderate risk drug or alcohol useExperimental Treatment1 Intervention
Subjects assigned to this condition will be instructed by the research assistant in how to download and use the eIntervention app, which they will be free to use as they like for the duration of the study. The app will contain a personalized suite of programs and activities. Unlike the TAU condition, the patient's referral to treatment would be managed through eIntervention. For example, the app will show the patient their referral details (if a referral to treatment was made), including details on the provider, referred services, and contact information, and will offer them videos of peers and professionals educating them on addiction, treatment, and sharing personal stories of recovery.
Group III: SBIRT/TAU for those with moderate risk drug or alcohol useActive Control1 Intervention
This moderate risk group will receive the standard Screening and Brief Intervention Treatment (SBIRT) along with Treatment as Usual (TAU) at the clinic.
Group IV: SBIRT/TAU for those assessed with high risk.Active Control1 Intervention
This high risk group will receive the standard Screening and Brief Intervention Treatment (SBIRT) along with Treatment as Usual (TAU) at the clinic.
Find a Location
Who is running the clinical trial?
Western Michigan UniversityOTHER
16 Previous Clinical Trials
2,678 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,735 Total Patients Enrolled
Chess Mobile HealthLead Sponsor
Hans MorefieldPrincipal InvestigatorCHESS Health